Concepedia

Christopher Viereck

CV

Statistics

Publications

8

Citations

1.4K

H-Index

8

Active since

1988

Affiliations

Amicus Therapeutics (United States)(Current)

Friedrich Miescher Institute

Université Paris-Saclay

Hôpital du Sacré-Cœur de Montréal

University College London

Christopher Viereck is an author at Amicus Therapeutics (United States) specializing in life sciences, pharmacotherapy, and pharmacology.

Publications per year

1988–2019

8

Publications

8

Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

Dominique P. Germain, Derralynn Hughes, Daniel G. Bichet et al. · New England Journal of Medicine · 2016 · 556 citations · Full text

, , +17

Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

Derralynn Hughes, Suma P. Shankar, Gere Sunder–Plassmann et al. · Journal of Medical Genetics · 2016 · 386 citations · Full text

, , +17

The adult rat olfactory system expresses microtubule-associated proteins found in the developing brain

Christopher Viereck, RP Tucker, Andrew Matus · Journal of Neuroscience · 1989 · 174 citations · Full text

, , +17

The sequential appearance of low- and high-molecular-weight forms of MAP2 in the developing cerebellum

RP Tucker, LI Binder, Christopher Viereck et al. · Journal of Neuroscience · 1988 · 97 citations · Full text

, , +14

Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study

Dominique P. Germain, Kathy Nicholls, Roberto Giugliani et al. · Genetics in Medicine · 2019 · 96 citations · Full text

, , +13

1–5 of 8